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Postoperative manifestation of heparin-induced
thrombocytopenia with intracavitary thrombosis:
Diagnostic pitfalls and conservative therapy
Helmut Gulbins, MD, Tito Chavez, MD, and Juergen Ennker, MD, Lahr, Germany
Thrombotic events after the administration of protaminein combination with aprotinin have been described. Inthe presented case, however, thrombosis occurred 6days after surgery, making this reason unlikely. The
transvalvular gradient and thrombocyte count were normal until
that time. Therefore, we think the thrombosis in this case was
attributable to the heparin-induced thrombocytopenia (HIT), which
was also proven by the enzyme-linked immunosorbent assay
(ELISA).
Clinical Summary
A female patient was admitted to our hospital with the diagnosis
of aortic stenosis and recurrent atrial fibrillation. Left ventric-
ular function was reduced (ejection fraction: 35%). Additional
diagnoses were arterial hypertension, diabetes mellitus, and
adiposity. She reported hyperergic reactions to several sub-
stances.
With the use of extracorporeal circulation, the aortic valve was
replaced with a stentless porcine valve (Freestyle, 23 mm,
Medtronic Inc, Minneapolis, Minn) as the total root. The left
pulmonary veins were isolated with a bipolar device (Cardioblate,
Medtronic Inc), and the left atrial appendage was ligated. During
extracorporeal circulation, 2 million IE of aprotinin were admin-
istered.
After an uneventful initial course with low transvalvular
gradients, a sudden decrease in platelet count to 27,000/L was
noticed on the sixth postoperative day. Echocardiography re-
vealed an increased transvalvular gradient (mean gradient: 30
mm Hg). A pf4-antibody agglutination test showed a negative
result. Regardless of this result, HIT was suspected and heparin
was stopped immediately. Systemic anticoagulation was estab-
lished with hirudin (7.2 mg/24 hours) and thrombocyte aggre-
gation inhibitors (acetylsalicylic acid, 100 mg/day). Transesoph-
ageal echocardiography revealed clot formations within the leaflets
and sinuses of the stent-
less valve, around the
central venous cathe-
ter, and within the left
atrium at the insertions
of the pulmonary veins
and the former orifice of
the left atrial appendage
(Figure 1, A, B). Two
days later, the ELISA
result for pf4-antibodies
was positive.
Under continuous anticoagulation with hirudin and controls
using transesophageal echocardiography, the clots disappeared
within 6 days without any embolic complications. The patient was
discharged with a pressure gradient via the aortic valvular pros-
thesis of 16 mm Hg (mean gradient) on the 20th postoperative day
for further rehabilitation.
Discussion
The incidence of HIT after cardiac surgery can be estimated to be
between 1% and 3%, whereas heparin-dependent antibodies de-
velop in 25% to 50% of patients after cardiac surgery.1 Heparin-
induced antibodies against the thrombocyte pf4-receptor may re-
sult in their activation with subsequent thrombotic and embolic
events. This is accompanied by a decrease in the platelet count2
caused by increased consumption. Intracavitary thrombosis within
the left and right sides of the heart developed in the presented case.
Because of the delay between surgery and thrombosis, this was
unlikely the result of intraoperative aprotinin administration. The
locations corresponded to endothelial damages or the lack of
endothelial coverage because of the operation: The endocardium
of the left atrium was damaged by the bipolar ablation and the
closure of the left atrial appendage, the implanted glutaraldehyde
fixed porcine valve lacked any endothelial covering, and the cen-
tral venous catheter was a foreign body. The clinical symptoms,
however, were only a decrease in platelet count in combination
with an increase in transvalvular gradient over the aortic valve
prosthesis. The patient’s history with a hyperergic reaction to
numerous substances made a pathologic reaction against heparin
likely. In addition, the diagnosis of HIT should be approved by
laboratory methods, but it may take several tests to gain the
definite diagnosis.3
The presented case had 3 negative pf4-antibody agglutination
test results. This screening test is quick and simple, but obviously
has too low a sensitivity to exclude the diagnosis of HIT. The
ELISA result for pf4-antibodies, however, was positive, underlin-
ing the higher sensitivity of this method for HIT detection. Even
with the ELISA, the presence of anti-pf4 antibodies can be
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proven only with a delay of more than 2 days in approximately
50% of patients in whom HIT develops.4 Therefore, the labo-
ratory tests can only serve as an approval of the clinical diag-
nosis, whereas therapy must be started earlier even with a negative
test result.
In clinical routine, the recommendation is to replace heparin
immediately whenever HIT is suspected. In the presented case,
platelet activation was stopped and thrombolysis resolved the clots
within a few days. This was possibly the result of the short time
interval between the onset of the platelet activation and the ther-
apeutic reaction.
Anticoagulative therapy is recommended using direct thrombin
inhibitors, such as hirudin or bivalirudin.5 Because these sub-
stances cannot be monitored as easily as heparin, care must be
taken that the correct dosage is administered, especially in patients
with renal insufficiency. Additional inhibition of platelet aggrega-
tion (cyclo-oxygenase or GP IIb/IIIa inhibitors) is also indicated.
The presented case demonstrated that this regimen can result in a
lysis of already initiated thrombosis.
Under heparin therapy, any decrease in platelet count in com-
bination with any suspected thrombotic events must result in an
immediate replacement of heparin by systemic alternatives, such
as hirudin analogs. Laboratory tests can prove the diagnosis of
HIT. With regard to the possible serious complications, therapy
should be initiated in the clinical situation.
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Figure 1. A, Transesophageal echocardiography showing thick-
ened leaflets (arrow) caused by fresh thrombosis. B, Transesoph-
ageal echocardiography showing thrombus originating from the
former origin of the left atrial appendage and the pulmonary veins
(thick arrow). Clot formation in the left and right coronary sinuses
(thin arrows).
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